Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Tinea capitis can occur in adults and should be considered if scalp issues persist.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

L-Carnitine-L-tartrate may help hair grow and prevent hair loss.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Upadacitinib effectively treats severe alopecia areata and is safe.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

The patch effectively promotes hair growth for alopecia areata without pain.

The serum effectively reduces hair loss and improves hair growth without side effects.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Alefacept showed some effectiveness for alopecia areata but needs more research.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Ethylenthiourea is toxic to the liver and nervous system, especially with alcohol.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.